期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 380, 期 23, 页码 2246-2255出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1807054
关键词
-
资金
- Alkermes
This review explains harm-reduction strategies for three groups of patients: those who have not received previous opioid therapy, those receiving long-term opioid therapy, and those with an opioid use disorder. It explains both risk assessment and the current approach to the use of medications for opioid use disorder.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据